The development of cutting-edge stethoscopes is being worked on by market participants in order to progress technology, which is predicted to drive the global esophageal stethoscope market's growth. For instance, the 3M Littmann CORE Digital Stethoscope, a smart digital stethoscope that enables for improved lung and heart disease diagnosis, was introduced in October 2020 by the conglomerate business 3M. It offers sound data visualisation during auscultation, the practise of listening to the body's internal sounds, as well as active noise reduction to decrease distracting background noise in operating rooms. The esophageal stethoscope market is anticipated to increase as a result of technological advancements in stethoscopes, especially esophageal stethoscopes. The expansion of the global esophageal stethoscope market is anticipated to be driven by research and development initiatives that will increase the manufacture of new esophageal stethoscopes. The system comprises of a transmitter that creates sound waves, amplifies them, and transmits them using a transmitter with frequency modulation. A receiver demodulates, amplifies, and sends the received signal to a headphone so the anesthesiologist may hear it.
According to Coherent Market Insights, The global Esophageal Stethoscope Market is projected to reach US$ 21.25 million in 2022 and is anticipated to grow at a CAGR of 4.1% from 2022 to 2030.
Leading Companies in the Esophageal Stethoscope Industry:
1. Medtronic
Minneapolis, Minnesota serves as the main location for Medtronic, which was founded there in 1949. It creates and produces medical technology and pharmaceuticals. The HeartWare Ventricular Assist System was subject to a commercial decision to recall in February 2021. The business announced in April 2022 that it will partner with GE Healthcare to meet the demands for care at ambulatory surgery centres. In October 2022, the company stated that it will investigate the possibility of splitting its integrated Patient Monitoring and Respiratory Interventions departments.
2. ICU Medical
The firm was founded in 1984 and is located in California, United States. The products of the company are made to stop IV lines from being accidentally disconnected and to shield healthcare professionals and their patients from the transmission of infectious diseases like hepatitis B and the human immunodeficiency virus (HIV). ICU Medical, Inc. announced in September 2021 that it will pay $2.35 billion in cash to acquire Smiths Group plc's Smiths Medical division.
